Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 26,011 | 26,704 | 6,828 | 41,980 | 47,110 |
| Depreciation Amortization | 66,159 | 44,362 | 21,918 | 54,454 | 34,699 |
| Income taxes - deferred | 2,895 | 2,193 | 29 | 10,872 | 12,953 |
| Accounts receivable | 2,847 | 5,213 | 4,215 | -10,434 | 3,070 |
| Accounts payable and accrued liabilities | 4,681 | 5,258 | 6,105 | -10,262 | -825 |
| Other Working Capital | -37,620 | -35,710 | -9,214 | -25,509 | -20,585 |
| Other Operating Activity | 38,264 | 12,563 | 896 | 64,616 | 26,080 |
| Operating Cash Flow | $103,237 | $60,583 | $30,777 | $125,717 | $102,502 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -17,187 | 9,057 |
| PPE Investments | -24,584 | -19,403 | -7,668 | -45,866 | -36,700 |
| Net Acquisitions | N/A | -32,000 | N/A | -424,042 | N/A |
| Purchase Of Investment | -332,426 | -200,391 | -168,351 | -602,431 | -530,679 |
| Sale Of Investment | 152,636 | 62,936 | N/A | 1,068,736 | 470,614 |
| Other Investing Activity | -32,000 | 0 | -32,000 | 0 | 0 |
| Investing Cash Flow | $-236,374 | $-188,858 | $-208,019 | $-20,790 | $-87,708 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 363,750 | N/A |
| Debt Repayment | -368,319 | -358,944 | -192,609 | N/A | 0 |
| Common Stock Issued | 25,302 | 23,702 | 11,024 | 26,655 | 20,623 |
| Other Financing Activity | 0 | 0 | 0 | -9,711 | -1,338 |
| Financing Cash Flow | $-343,017 | $-335,242 | $-181,585 | $380,694 | $19,285 |
| Beginning Cash Position | 585,578 | 585,578 | 585,578 | 99,957 | 99,957 |
| End Cash Position | 109,424 | 122,061 | 226,751 | 585,578 | 134,036 |
| Net Cash Flow | $-476,154 | $-463,517 | $-358,827 | $485,621 | $34,079 |
| Free Cash Flow | |||||
| Operating Cash Flow | 103,237 | 60,583 | 30,777 | 125,717 | 102,502 |
| Capital Expenditure | -24,584 | -19,403 | -7,668 | -45,866 | -36,700 |
| Free Cash Flow | 78,653 | 41,180 | 23,109 | 79,851 | 65,802 |